Design Therapeutics, Inc.
SEC Filing List

DSGN         CIK: 0001807120

Form Description Owner/Filer Filing Agent Date Actions
8-KCurrent report filingDesign Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/28/2026
10-QQuarterly report pursuant to Section 13 ...Design Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/28/2026
DEF 14ADefinitive proxy statementsDesign Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/23/2026
ARSAnnual report to security holdersDesign Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/23/2026
DEFA14ADefinitive additional proxy soliciting m...Design Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/23/2026
3Initial statement of beneficial ownershi...Shapiro DavidDesign Therapeutics, Inc.04/01/2026
4Statement of changes in beneficial owner...Shapiro DavidDesign Therapeutics, Inc.04/01/2026
8-KCurrent report filingDesign Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/04/01/2026
SCHEDULE 13D/AGo2 EDGAR SOLUTIONS LLC /fa03/11/2026
S-8Initial registration statement for secur...Design Therapeutics, Inc. DONNELLEY FINANCIAL SOLUTIONS /FA/03/09/2026
No record found.
Load More